University of California San Francisco at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
University of California San Francisco brings 5 presentations to AMP 2026 in Seattle. Its sessions cover solid tumor genomics, prenatal genetic testing, and laboratory and computing workflows. Presentations include methylation-based recurrence risk in low-grade uterine endometrioid adenocarcinoma, the diagnostic yield of prenatal genomic sequencing, and benchmarking GPU-accelerated variant calling against a standard pipeline.
| Organization | AMP 2026 Attendance |
|---|---|
University of California San Francisco San Francisco, CA | |
Public health sciences university in San Francisco with clinical laboratories and research in genomics and molecular diagnostics. | Talk Thu, Nov 12 11:15am–11:45am Novel Mutational Signatures in Cancer Two newly described mutational signatures, one tied to antiretroviral drugs and one to aristolochic acid. Workshop Thu, Nov 12 3:45pm–4:15pm Optimized Automated Extraction for FFPE Tissue Cores Automated simultaneous DNA and RNA extraction from FFPE cores and sections, validated for sequencing-grade yield. Talk Sat, Nov 14 10:45am–11:15am Diagnostic Yield of Prenatal Genomic Sequencing Diagnostic yield of exome and genome sequencing for fetal anomalies, including variants of uncertain significance. Poster Sat, Nov 14 1:45pm–2:00pm |
Instantly find 20 buyers from University of California San Francisco
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction